Home › GenVec Inc (GNVC) Rating Increased to Buy at Zacks Investment Research
 

Keywords :   


GenVec Inc (GNVC) Rating Increased to Buy at Zacks Investment Research

2016-02-06 19:17:43| Biotech - Topix.net

The firm currently has a $0.50 price objective on the biopharmaceutical company's stock. Zacks Investment Research 's price target indicates a potential upside of 2.02% from the company's previous close.

Tags: buy research rating increased

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 11
05.10Hurricane Leslie Wind Speed Probabilities Number 11
05.10Hurricane Leslie Public Advisory Number 11
05.10Summary for Hurricane Leslie (AT3/AL132024)
05.10Hurricane Leslie Forecast Advisory Number 11
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 23
More »